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AlthoughessentialforTcellfunction,theidentityoftheTcell
receptor (TCR) “inside-out” pathway for the activation of lym-
phocyte function-associated antigen 1 (LFA-1) is unclear.
SKAP1 (SKAP-55) is the upstream regulator needed for TCR-
induced RapL-Rap1 complex formation and LFA-1 activation.
Inthispaper,weshowthatSKAP1isneededforRapLbindingto
membranesinamannerdependentonthePHdomainofSKAP1
andthePI3Kpathway.ASKAP1PHdomain-inactivatingmuta-
tion (i.e. R131M) markedly impaired RapL translocation to
membranes for Rap1 and LFA-1 binding and the up-regulation
of LFA-1-intercellular adhesion molecule 1 (ICAM-1) binding.
Further, N-terminal myr-tagged SKAP1 for membrane binding
facilitated constitutive RapL membrane and Rap1 binding and
effectively substituted for PI3K and TCR ligation in the activa-
tion of LFA-1 in T cells.
Integrins regulate T cell migration to sites of inflammation,
movementinlymphnodes,andconjugateformationbetweenT
cells and antigen-presenting cells (1–3). They comprise as
many as 20  heterodimers that are activated by changes in
conformation and clustering (2, 3). T cell function is primarily
regulated by the 2 family members, such as lymphocyte func-
tion-associated antigen (LFA-1,
2 L (CD11a)/2 (CD18)) and
4 integrins such as 41 (Very Late Antigen-4 (VLA-4)).
Bindingtointercellularadhesionmolecule1(ICAM-1)ismedi-
ated by the LFA-1  and  subunits that interact to create a
headpieceinthesubunit,termedtheI-likedomain(4).LFA-1
binds to ICAM-1 and ICAM-2 on major histocompatibility
complex bearing antigen-presenting cells (5).
While in low-affinity conformation on resting T-cells, TCR
and chemokine receptor ligation generates “inside-out” signals
that activate integrins (3, 6, 7). Generic upstream regulators of
the pathway include the CD4- and CD8-p56
lck complexes
(8–10), IL-2-inducible T cell kinase (11), the guanine nucleo-
tide exchange factor Vav-1 (12), PI3K (13), and GTP binding
proteins such as Rac/Rho (14).
Despitethis,amajorchallengehasbeentoidentifythedirect
downstream mediators of the pathway. Prime candidates
include the GTP binding protein Rap1 (15, 16) and its binding
partner RapL (regulator of cell adhesion and polarization
enriched in lymphoid tissues) and RIAM (Rap1-interacting
adaptor molecule) (17, 18). RapL (MAXP1, NORE1B, RASSF3)
is an immune cell-specific isoform of the RASSF5 (Ras associa-
tion domain family 5) family. It has an unique N terminus fol-
lowedbyaRas-associatingdomain(RA)andC-terminalcoiled-
coil (Sav/RassF/Hpo domain (SARAH)) domain (17). The RA
domain binds GTP-bound active Rap1, whereas the SARAH
domain binds the coiled-coil domain of the serine kinase mac-
rophage-stimulating 1 (MST-1) (17, 18). RapL binds directly to
the LFA-1  chain cytoplasmic tail (17, 18).
At the same time, immune cell-specific adaptor proteins
SLP-76 (76-kDa src homology 2 domain-containing leukocyte
phosphoprotein) (19), ADAP (adhesion and degranulation-
promoting adaptor protein) (HUGO official designation: Fyb)
(20–25) and SKAP1 (HUGO official designation: src kinase-
associated phosphoprotein 1, also SKAP-55, src kinase-associ-
ated phosphoprotein 55) are needed for T cell adhesion (26–
29). SLP-76 binds Vav1 as mediated by ZAP-70 phosphor-
ylation (30, 31), whereas ADAP is comprised of a unique NH2
terminus, an internal SH3 domain, two nuclear localization
sequences, and a C-terminal SH3-like domain (20, 32). Src
kinasep59
fynTphosphorylatestwoYDDVmotifsonADAPthat
are needed for SLP-76 SH2 domain binding (33, 34). Mutation
of the YDDV sites reduces LFA-1-ICAM1 adhesion, T cell-an-
tigen-presenting cell conjugate formation and formation of the
peripheral supramolecular activation complex (26, 35). At the
same time, ADAP forms a complex with SKAP1, an adaptor
with a unique NH2-terminal region followed by a PH domain
and a carboxy-terminal SH3-like domain (36–38). The com-
plex is mediated by SKAP1 SH3 domain binding to a proline
residueintheADAPand,toalesserextent,theADAP-SH3-like
domain binds to unique sequences in SKAP1 (37–39). One key
function of ADAP is to protect SKAP1 from proteolytic degra-
dation (40). Retroviral transduction and shRNA knockdown
first implicated SKAP1 in adhesion (21, 22, 27, 41), whereas
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 Skap1
/ mice possess T cells with defective  and 2 integrin
function at levels similar to that observed in Adap
/ (Fyb
/)-
deficientTcells(42).UnlikewithAdap
/Tcells,whichshowthe
concurrent loss of SKAP1 (23, 24), Skap1
/T cells retain ADAP
expression (42). This phenotype pointed to SKAP1 as the effecter
of LFA-1 activation in the ADAP-SKAP1 module.
Despite the initial evidence for separate pathways, a recent
study by us demonstrated that SKAP1 and Rap1-RapL are
interconnected in the context of TCR-induced inside-out sig-
naling (43). SKAP1 was found to act as the upstream regulator
of RapL-Rap1 complex formation on the basis of the observa-
tion that RapL-Rap1 complexes fail to form in the absence of
SKAP1 (43). SKAP1 also binds directly to the coiled-coiled
SARAHdomainofRapLandcancompeteforMST1bindingto
the same region (18, 43). Further, a RapL SARAH domain
mutation that disrupts SKAP1 binding without affecting
MST-1 impaired T-cell binding to ICAM1 on dendritic cells
and reversed the ability of RapL to reduce T cell motility (i.e.
slowing) in lymph nodes (34). Further, the SKAP1 pathway
appears preferentially coupled to TCR inside-out signaling
becauseSkap1
/T-cellsshowonlyamildlossofmigrationto
chemokines such as CXCL12 (44).
Despite these advances, the manner by which SKAP1 regu-
lates Rap1-RapL complex formation and its connection to the
PI3K pathway has been unclear. In this paper, we show that
SKAP1 is needed for RapL binding to membranes in a manner
dependentonthePHdomainofSKAP1andthePI3Kpathway.
EXPERIMENTAL PROCEDURES
Cells and Antibodies—Primary T cells and Jurkat cells were
cultured in RPMI 1640 medium with 10% (v/v) fetal calf serum
and1%(w/v)penicillin/streptomycin.MurinehybridomaT8.1-
expressing TCR specific for Ttox (830–843) was a gift of Pro-
fessor O. Acuto, Oxford University. Transfection was per-
formed by electroporation (Bio-Rad). Anti-SKAP1 (BD
Transduction Laboratories), anti-V5 (Invitrogen), anti-Rap1
and anti-p-glycogen synthase kinase 3 (GSK3) (Cell Signaling
Technology, Inc.), anti-RapL (GenWay Biotech, Inc.), anti-
FLAGandanti--actin(Sigma),anti-GFP(SantaCruzBiotech-
nology, Inc.), anti-human CD3 (American Type Culture Col-
lection), anti-mouse CD3 (2C11, hamster anti-mouse CD3),
and anti-CD18 (anti-LFA-1) (Epitomics, Inc.). Wortmannin
and LY294002 (Cell Signaling Technology, Inc.) and anti-mu-
rine ICAM1-FC was purchased from R&D Systems (MN).
Generation of Plasmids and Mutagenesis—Full-length
human SKAP1 cDNA were cloned into the pSRa expression
vector and in-frame with the NH2 terminus of the GFP gene
(Promega Corp.) and in the pcDNA 3-FLAG vector (Invitro-
gen). Human RapL was cloned into the pcDNA3.1-V5 expres-
sion vector (Invitrogen). The SKAP1-R131M mutant and the
myr-tagged version were generated by site-directed mutagene-
sis (Stratagene).
ImmunoprecipitationBlotting—Precipitationwasconducted
by incubation of the lysate with the antibody for 1 h at 4 °C,
followedbyincubationwith30lofproteinG-Sepharosebeads
(10% w/v) for1ha t4° C .Immunoprecipitates were washed
three times with ice-cold lysis buffer and subjected to SDS-
PAGE. For blotting, precipitates were separated by SDS-PAGE
and transferred onto nitrocellulose filters (Schleicher and
Schuell).Boundantibodywasrevealedwithhorseradishperox-
idase-conjugated rabbit anti-mouse antibody using enhanced
chemiluminescence (ECL, Amersham Biosciences). For purifi-
cation of membrane fractions, Jurkat or primary T cells were
sheared in hypotonic buffer and the nuclei removed by low-
speed centrifugation (1500 rpm, 10 min), and the supernatant
was recentrifuged at high speed (25,000 rpm) for 1 h. The cyto-
solic fraction comprised the supernatant, whereas membranes
remained in the pellet.
Integrin Adhesion Assay—For ICAM-1 binding, flat-bot-
tomed 96-well plates were coated with 4 g/ml murine
ICAM-1humanFcinPBSovernightat4 °C,washedwithRPMI
medium, and blocked with 2.5% BSA in PBS for1ha t3 7° C .
Transfected T8.1 hybridoma cells were stimulated by incuba-
tion with 5 g/ml anti-CD3 (mAb 2C11) followed by cross-
linking with 2.5 g/ml of goat anti-hamster IgG for 30 min at
37 °C.Stimulatedcells(1–2105cells/well)wereaddedtothe
murineICAM-1-Fc-coatedplates.Plateswereincubatedfor30
minat37 °C.Nonadherentcellswereremovedbywashing.The
number of adherent cells were counted.
RESULTS
SKAP1BindingandRapLTranslocationtoMembranesIsPH
Domain-dependent—To test for the role of the SKAP1 PH
domain in the formation of the SKAP1-RapL-Rap1 complex,
Flag-tagged SKAP1 WT and a mutant with a PH domain inac-
tivating mutation at 131 (i.e. R131M) were generated and
expressed in Jurkat cells with V5-tagged RapL (Fig. 1). Cells
were left untreated or ligated with anti-CD3 for 5 min. Anti-
FLAG SKAP1 readily coprecipitated SKAP1 from membranes
of resting and anti-CD3-ligated cells (Fig. 1, left panel, lanes 5
and 6). The presence of SKAP1 increased with anti-CD3 liga-
tion (Fig. 1, left panel, lane 6 versus lane 5). By contrast, mark-
edly reduced amounts of SKAP1 R131M were precipitated
from resting and anti-CD3-ligated cells (Fig. 1, left panel, lanes
11 and 12). A slight increase in R131M was occasionally
observed in response to anti-CD3 (Fig. 1, left panel, lane 12
versus lane 11). However, this occurred at levels far lower than
observed with SKAP1 WT (i.e.  10%). Similarly, anti-SKAP1
coprecipitatedRapLfrommembranesofanti-CD3-ligatedcells
(Fig. 1, left panel, lane 6) but not resting cells (lane 5) or cells
transfected with R131M (lanes 11 and 12). As a control, the
blotting of solubilized cytosolic and membrane fractions
showed that anti-CD3 induced an increase in the presence of
SKAP1andRapLinthemembranefractionofSKAP1WT(Fig.
1, right panel, lane 5 and 6) but not in R131M-transfected cells
(lanes 9 and 10). Further, expression of R131M prevented the
appearance of RapL in the membrane fraction (Fig. 1, right
panel, lanes 9 and 10 versus lanes 4 and 5). In this manner,
R131M acted as a dominant negative in overriding the positive
effectofendogenousSKAP1onthetranslocationofRapLtothe
membranes.
ExpressionofR131Mhadmuchlesseffectonthelocalization
of Rap1 to the membrane fraction (Fig. 1, right panel). Anti-
CD3 increased levels of Rap1 in the membrane fraction in
SKAP1 WT and R131M-expressing cells (Fig. 1, right panel,
lanes 4 and 5 and lanes 9 and 10). The increase in R131M cells
SKAP1-RapLMediationoftheTCR“Inside-out”Pathway
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 was occasionally observed to be slightly less than in WT
SKAP1-expressing cells. As a control, actin did not change in
the fractions from transfected cells (Fig. 1, right panel). These
observations showed that SKAP1 membrane localization in
response to anti-CD3 is PH domain-dependent and, secondly,
that RapL membrane localization is dependent on SKAP1
membrane binding and its PH domain.
SKAP1 Binding and RapL Translocation to Membranes Is
PI3K-dependent—PH domains bind to D-3 lipids generated by
PI3K(45).ToconfirmthatPI3KactivitywasneededforSKAP1
translocation, the effect of wortmannin and LY294002, inhibi-
tors of PI3K, was assessed (Fig. 2). Mouse splenocytes were
incubated with the PI3K inhibitors for 30 min prior to ligation
withanti-CD3followedbyisolationofcytosolicandmembrane
fractions and immunoblotting using the designated antibodies.
The anti-CD3-induced translocation of WT SKAP1 to the
membranefractionwasblockedbyeachinhibitor(Fig.2,upper
panel, lanes 11 and 12 versus lane 10). There was a concurrent
increase in its presence in the cytosolic fraction (Fig. 2, upper
panel, lanes 7 and 8 versus lane 6). Significantly, again, this
effect on SKAP1 was mirrored by impaired RapL translocation
to the membranes (Fig. 2, upper panel, lanes 11 and 12 versus
lane10).Further,consistentwithpreviousresults,thepresence
of Rap1 was unaffected by inhibition of PI3K (Fig. 2, upper
panel, lanes 9–12). Inhibition of PI3K was confirmed by inhi-
bition of protein kinase B (PKB)/AKT phosphorylation of
GSK3 (Fig. 2, lower panel, lanes 3 and 4 versus lane 2). These
results confirmed the importance of PI3K activity in the trans-
location of SKAP1 and RapL to the membranes of cells.
SKAP1 PH Domain Is Needed for LFA-1 Binding and TCR-
inducedICAM-1Adhesion—Wenextaskedwhethertheinabil-
ity of the R131M mutant to translocate to the membranes
affected binding to CD18 (Fig. 3A). We showed previously that
SKAP1 forms a trimeric complex with RapL and Rap1 that
binds to LFA-1 (43). Jurkat cells were transfected with FLAG-
SKAP1, V5-RapL, and Rap1V12 and cross-linked with anti-
CD3 followed by membrane isolation and immunoprecipita-
tion with anti-FLAG. Blotting was then conducted using
anti-CD18 (Fig. 3A, upper panel) or anti-FLAG (lower panel).
Although anti-FLAG-SKAP1 precipitated CD18 in a CD3 liga-
tion-dependentmanner(Fig.3,lane3versuslane2),itfailedto
precipitate CD18 from cells transfected with the R131M
mutant (upper panel, lanes 6 and 5). Further, the absence of
R131M translocation to the cell surface for binding to LFA-1
was seen by fluorescence microscopy (Fig. 3B, left panels).
Although anti-CD3 induced the localization of GFP-SKAP1
WT to the periphery of cells, it failed to induce the transloca-
tionoftheGFP-R131Mmutant,whichremainedinthecytosol.
The lower histogram shows the relative difference in the cell
number with cell surface staining.
TotestforTCR-inducedinsideoutsignaling,theadhesionof
T cells to ICAM-1 on plates was tested (Fig. 3C). For this, T8.1
cells were transfected and plated on ICAM-1-coated plates fol-
FIGURE 1. SKAP1 PH domain mediates anti-CD3 induced SKAP1 and RapL localization to membranes. FLAG-tagged SKAP1 WT or the mutant form of
SKAP1 at R131M were coexpressed in Jurkat cells with V5-tagged RapL. Cells were either left untreated or ligated to anti-CD3 for 5 min prior to precipitations
(IP) with anti-FLAG followed by blotting with anti-FLAG (upper panel) or anti-V5 (lower panel). Left panel, shown are FLAG-SKAP1-WT and V5-RapL (lanes 1–6)
andFLAG-SKAP1-R131MandV5-RapL(lanes7–12).Rightpanel,lysatestransfectedwithFLAG-SKAP1WTorFLAG-SKAP1R131MandV5-RapLwereblottedwith
anti-FLAG, anti-V5, anti-Rap1, and anti--actin.
FIGURE 2. SKAP1 PH domain membrane association and regulation of
RapLisPI3K-dependent.Tcellsplenocyteswereligatedwithanti-CD3for5
min in the presence or absence of wortmannin or LY294002 (i.e. 30-min pre-
incubation), followed by separation into cytosolic and membrane fractions.
Immunoblotting was conducted using the designated antibodies. Upper
panel,lysateswereblottedwithanti-SKAP1,anti-RapL,anti-Rap1,andanti--
actin. Lower panel, control for LY294002 and wortmannin inhibition of PI3K.
Splenocytes were ligated as described above, followed by immunoblotting
with anti-pGSK3.
SKAP1-RapLMediationoftheTCR“Inside-out”Pathway
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 lowed by the addition of anti-CD3, as described previously (26,
27, 42, 43, 44). Although suboptimal anti-CD3 induced a mar-
ginal increase of the binding of cells to ICAM-1 on plates in
mock-transfected T8.1 T cells (i.e. from 17 to 20% of cells),
transfected WT SKAP1 induced a major increase of binding
involving 37% of cells (p  0.0006). By contrast, the R131M
mutant, although providing some increase in adhesion, was
impaired relative to WT SKAP1 (38 versus 30%). These obser-
vations confirm that the PH domain of SKAP1 mediates local-
izationandpromotionofRapLtomembranesandisneededfor
optimal augmentation of TCR-induced LFA-1 adhesion to
ICAM-1.
Myr-SKAP1SubstitutesforTCRintheInductionofConstitu-
tively Enhanced T cell Adhesion—The next question was
whether the involvement of the PH domain was strictly due to
its role in membrane localization and whether constitutive
membrane localization could overcome the need for the PH
domain. To assess this, a MGCVQCDKD-myristoylation tag
was fused to the N terminus of WT SKAP1, and the R131M
mutantwasfollowedbyexpressioninT8.1Tcells.Myr-SKAP1
was found constitutively associated with the membrane frac-
tion of resting and anti-CD3-ligated cells (Fig. 4A, upper panel,
lanes 7 and 8). The level of binding in resting cells was compa-
rable for the WT SKAP1 induced by anti-CD3 (Fig. 4A, upper
panel, lanes 7 and 8 versus lane 4), and the level of myr-SKAP1
did not increase further with anti-CD3 ligation (lane 8 versus
lane7).Similarly,myr-SKAP1R131Mconstitutivelyassociated
with membranes (Fig. 4A, lower panel, lanes 7 and 8). The level
was much greater than the small increase in anti-CD3-induced
SKAP1 R131M (Fig. 4A, lower panel, lane 4 versus lane 3)( i.e. a
reduction of 60%).
Similar results were obtained in 293T cells, where both myr-
SKAP1 WT and the myr-SKAP1 R131M mutant constitutively
associatedwithmembranes(Fig.4B,lanes4and8).SKAP1WT
and SKAP1 R131M were found mostly in the cytosolic fraction
(Fig. 4B, lanes 1 and 5). In the case of T cells, this constitutive
bindingofmyr-SKAP1WTandmyr-SKAP1R131Msupported
coprecipitation of cotransfected RapL from the membrane
fraction of resting and anti-CD3-ligated cells (Fig. 4C, lower
panel, lanes 5 and 6 and lanes 11 and 12). These data indicate
thatmyr-taggedSKAP1canbypasstheneedforthePHdomain
in RapL and membrane binding.
Totestfortheeffectofmyr-SKAP1onadhesion,transfected
T8.1TcellswereassessedforbindingtoICAM-1onplates(Fig.
5A). Myr-SKAP1 WT showed constitutively elevated ICAM-1
adhesion, effectively bypassing the need for anti-CD3 (i.e.
45–50%). Myr-SKAP1 R131M showed similarly high levels of
constitutive binding (i.e. 35%). A small additional increase was
observed with anti-CD3 (i.e. 47%). A titration of 1 versus 5
g/ml anti-CD3 showed that myr-SKAP1 or myr-SKAP1-
R131M induced the same level of adhesion in the absence of
anti-CD3 that was normally induced with anti-CD3 (Fig. 5B).
Immunoblotting showed the level of expression of the trans-
fected and endogenous SKAP1 proteins (Fig. 5B, right panel).
Identical results were obtained with primary murine T-cells
(Fig. 5C). Preactivated murine spleen T cells were rested for
FIGURE3.SKAP1PHdomainmutantR131MshowsreducedCD18bindingandLFA-1adhesion.A,JurkatcellsweretransfectedwithFLAG-taggedSKAP1
WTorFLAG-taggedSKAP1R131MplusV5-RapLandRap1V12,followedbyprecipitationwithanti-FLAGandblottingwithanti-CD18(upperpanel)oranti-FLAG
(lowerpanel).B,JurkatcellstransfectedwithGFP-SKAP1orGFP-SKAP1R131Mwereimagedformembranelocalization(upperpanels).Thelowerpanelsshows
the percent cell number with SKAP1 in the plasma membrane. C, T8.1 cells transfected with SKAP1 WT or SKAP1 R131M were assessed for binding to ICAM-1
onplatesasdescribedunder“ExperimentalProcedures.”ErrorbarsrepresentS.D.ForpairedT-tests,experimentalgroupswerecomparedwiththeirrespective
groups. Significant differences (p  0.05) are indicated with asterisks.
SKAP1-RapLMediationoftheTCR“Inside-out”Pathway
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 12hpriortotransfectionwithmyr-SKAP1wildtype.Anti-CD3
induced an increase in binding to ICAM-1 on plates (i.e. 15 to
38%). Myr-SKAP1 transfected T cells showed binding to
ICAM-1 at the same level as with anti-CD3 ligation of non-
transfected cells (i.e. 41 versus 38%). Anti-CD3 was not able to
increase adhesion more than supported by transfection of cells
with myr-SKAP1 (i.e. 43 versus 41%, p  0.173). These data
show that myr-SKAP1 can substitute for anti-CD3 in the acti-
vation of T cell adhesion.
SKAP1 Bypasses the Need for PI3K Regulation of T Cell
Adhesion—Previous studies have implicated PI3K in the TCR
induction of LFA-1 adhesion (13, 46). Given the PH domain
binding to D-3 lipids and the ability of myr-SKAP1 to replace
the TCR signal for adhesion, we next examined whether the
SKAP1-RapL connection could account for PI3K regulation of
T cell adhesion (Fig. 6). T8.1 T cells were incubated with the
PI3K inhibitor wortmannin for 30 min prior to anti-CD3 liga-
tion and isolation of membranes from transfected cells. This
wasfollowedbyblottingwithanti-GFPfordetectionofSKAP1.
Although the movement of WT SKAP1 to membranes was
inhibited by wortmannin (Fig. 6A, lane 2 versus lane 1), the
presence of myr-SKAP1 WT (lanes 3 and 4) and myr-SKAP1-
R131M (lanes 7 and 8) was unaffected (upper panel). SKAP1-
R131M failed to associate with membranes in the presence or
absenceofwortmannin(Fig.6A,lanes5and6).Theseobserva-
tions confirmed that PI3K activity was not needed for myr-
SKAP1 binding with the membrane fraction.
IntermsofICAM-1binding,wortmannininhibitedthebind-
ing to ICAM-1 induced by the combination of anti-CD3 with
SKAP1-WT expression (Fig. 6B). The level of binding was sim-
ilar to that observed with SKAP1-R131M expression with or
withoutwortmannin(i.e.20%).Bycontrast,theexpressionof
myr-SKAP1 WT or myr-SKAP1-R131M induced high levels of
T cell binding to ICAM-1 at 40–50% of the population. This
level of binding was observed in the presence or absence of
wortmannin. Further, the level was similar or slightly higher
than that observed with anti-CD3 plus SKAP1 WT in the
absenceofthedrug.ThesefindingsshowthatSKAP1inducesa
majorincreaseinLFA-1functionwhenconstitutivelyboundto
membranes and effectively overrides the need for PI3K in T
cells.
DISCUSSION
We previously showed that the immune cell adaptor SKAP1
is an essential upstream regulator of RapL-Rap1 complex for-
mation induced by ligation of the TCR complex (43). Despite
this, the detailed mechanism by which SKAP1 regulates com-
plex formation has been unclear. In this study, we have shown
that the SKAP1 PH domain is needed for the translocation of
itselfandRapLtomembranesofTcellsinresponsetoanti-CD3
FIGURE4.Myr-SKAP1bindstothemembraneandRapLinananti-CD3-independentmanner.A,T8.1TcellsweretransfectedwithSKAP1WTormyr-SKAP1
(upper panel) or SKAP1 mutant R131M or myr-SKAP1 mutant R131M (lower panel) and assessed for association with the cytosol or membranes. Lysates were
blottedwithanti-GFPandanti--actin(lanes1–8).B,293TcellsweretransfectedwithSKAP1WTormyr-SKAP1andassessedforassociationwiththecytosolor
membranes. Lysates were blotted with anti-GFP and anti--actin (lanes 1–8). C, T8.1 T cells were transfected with the myr-SKAP1 WT or myr-SKAP1 mutant
R131M plus V5-RapL. Anti-SKAP1 was used to precipitate GFP-SKAP1 (upper panel) or to coprecipitate V5-RapL (lower panel). Blotting was conducted with
anti-GFP (upper panel) and anti-V5 (lower panel).
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 ligation. This, in turn, was needed for optimal binding to Rap1
and activation of LFA-1. Myr-tagged SKAP1 and R131M
resultedinconstitutivemembranebindingofSKAP1andRapL
and, remarkably, substituted for TCR ligation and PI3K in the
inductionofLFA-1adhesioninT8.1andprimaryTcells.These
observations underscore the importance of SKAP1 in TCR and
PI3K up-regulation of LFA-1 adhesion.
We showed previously that RapL-Rap1 complex formation
anditsbindingtoLFA-1failedtooccurinSkap1
/Tcellsand,
secondly,thatTCRregulationofadhesiondependedonSKAP1
N-terminal binding to the SARAH domain of RapL (43). The
presence of a PH domain in SKAP1 suggested the possibility
that it might respond to PI3K-generated PIP3 for membrane
localization and, in the process, indirectly control the mem-
brane localization of RapL for an interaction with Rap1 and
LFA-1. The PH domain of related SKAP2 has been shown pre-
viously to bind D-3 lipids (47). We have found that SKAP1 and
RapLtranslocatetothemembraneuponTCRligation(43)(Fig.
1). The SKAP1-R131M PH domain mutation abrogated this
anti-CD3-induced translocation of SKAP1, as detected bio-
chemically from isolated membranes (Fig. 1) and by impaired
plasma membrane localization seen by immunofluorescence
staining of cells (Fig. 3). Further, SKAP1-R131M also impaired
the localization of RapL to the membrane fraction. Transloca-
tion was reduced by more than 80% in the presence of R131M.
The remaining translocation is likely due to the presence of
endogenous wild-type SKAP1 in cells.
Conversely, myr-SKAP-1 and myr-SKAP1-R131M constitu-
tively associated with membrane binding and, concurrently,
restoredRapLmembranebinding,confirmingtheessentialrole
of SKAP1 membrane binding for the membrane localization of
RapL. These observations support a model where SKAP1 acts
asashuttleforRapLtranslocationtomembranes,suchasinthe
case of RIAM and talin (48) or, alternatively, acts as a mem-
FIGURE 5. Myr-SKAP1 induced LFA-1 adhesion in an anti-CD3-independent manner. A, T8.1 cells were transfected with either mock, SKAP1 WT, SKAP1
R131M, myr-SKAP1-WT, or myr-SKAP1-R131M and assessed for binding to ICAM-1 on plates as described under “Experimental Procedures.” B, as above, but
with anti-CD3 titration (left panel). Lysates of transfected T8.1 cells were blotted with anti-GFP, anti-SKAP1, and anti--actin (right panel). C, primary mouse T
cellsweretransfectedwitheithermockormyr-SKAP1WTandassessedforbindingtoICAM-1onplates.ErrorbarsrepresentS.D.Forpairedttests,experimental
groups were compared with their respective groups. Significant differences (p  0.05) are indicated with asterisks.
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 brane-linked anchor for RapL binding. This latter interpreta-
tion is supported by our observation that it was difficult to
detect SKAP1-RapL complexes in the cytosol prior to their
appearance in the membrane. On the other hand, it is possible
that these complexes are transported too rapidly to the mem-
brane fraction for detection using biochemical approaches.
By contrast, SKAP1-R131M had far less effect on the anti-
CD3-induced increase in Rap1. TCR ligation is known to acti-
vate membrane-associated Rap1 to an active GTP-bound form
(15,16).AsubstantialincreaseinmembraneRap1wasnotedin
the presence of SKAP1-WT and SKAP1-R131M. This is con-
sistentwithourpreviousfindingthatRap1isfoundinthemem-
branes of cells in Skap1
/ T-cells (43). Occasionally, the level
of Rap1 was reduced by some 20–30%, consistent with some
effect of SKAP1 on Rap1 membrane localization (28). At the
same time, anti-CD3-induced activation of Rap1 is needed for
SKAP1-RapLbindingtotheprotein,leadingtotheformationof
the SKAP1-RapL-Rap1 complex (43). In this context, Rap1 can
also bind to other proteins, such as RIAM. Distinct pools of
Rap1 are likely to exist that regulate distinct events. It remains
to be determined whether Rap1 is limited in expression so that
its involvement in the SKAP1-RapL might compete for RIAM-
talin binding and vice versa, or whether it is expressed at suffi-
ciently high levels to accommodate the dual coordinate regula-
tion of both sets of complexes.
The importance of SKAP1 for LFA-1 activation was further
underscored by the effect of myr-SKAP1 on adhesion (Figs.
4–6). Constitutive membrane binding of myr-SKAP1 was able
to substitute for TCR ligation in the up-regulation of LFA-1
adhesion (i.e. via inside-out signaling). This was achieved with
only 2- to 3-fold over-expression relative to endogenous levels
ofSKAP1andwasobservedinT8.1andprimaryTcells.Expres-
sionofeithermyr-SKAP1-WTormyr-SKAP1-R131Minduced
a level of adhesion in the absence of anti-CD3 ligation that was
achieved by a combination of anti-CD3 plus SKAP1-WT or
anti-CD3 alone. Myr-SKAP1 was also able to associate with
RapL in the membrane in an anti-CD3-independent fashion
(Fig. 4C). These results show that the constitutive binding of
SKAP1 to the membranes of cells can suffice to replace the
anti-CD3-induced inside-out pathway for LFA-1 adhesion.
Further, our findings also demonstrate for the first time the
connectionbetweenSKAP1-RapL-Rap1andthePI3Kpathway.
Although inhibitors of PI3K effectively impaired TCR adhe-
sion, expression of myr-SKAP1 simply overrode this blockade
and supported normal levels of adhesion. This was a surprise,
giventheabilityofPI3Ktoregulatethetranslocationandactiv-
ity of numerous proteins with PH domains in cells. For exam-
ple, one would have expected that other PH domains, such as
RIAM, would be needed. This was under conditions where
wortmannin inhibited more than 98% of GSK-3 phosphoryla-
tion by AKT/PKB, an accepted surrogate for PI3K activity (Fig.
2). Although it would be unrealistic to claim that SKAP1 is the
sole mediator of PI3K dependence in the regulation of adhe-
sion, these observations confirm the potent role of SKAP1 in
promoting PI3K-dependent adhesion. It also begins to suggest
thattheremayexistdistinctpathways(e.g.SKAP-1-RapL-Rap1
and RIAM-talin) that can activate LFA-1 adhesion.
Further work is needed to establish the degree to which the
SKAP1-RapL pathway accounts for the TCR inside-out path-
wayinTcells.Inthecontextoflow-intermediatestrengthTCR
signals, our previous work has shown that the pathway
accounts for 50–70% of adhesion (42). Similar levels of
impaired inside-out-driven LFA-1 adhesion have also been
observed in Fyb
/ (Adap
/) T cells to peptides of differing
affinities (48, 49). However, the dependence on SKAP1 and
ADAP varies with the strength of the TCR signal. Higher-
strengthanti-CD3signalingcanoverridetheneedforSKAP1in
the up-regulation of adhesion, indicating that an alternate
pathway exists (3, 42, 48). ADAP binding to SLP-76 upstream
also regulates outside-in signaling for costimulation (25). Fur-
ther work will be needed to establish the identity of other pos-
sible inside-out pathways coupled to the TCR complex.
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